Skip to main content

Autoimmunity in Cardiomyopathies

  • Chapter
Cardiomyopathies and Heart Failure

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 248))

  • 129 Accesses

Abstract

Among various forms of cardiomyopathies, dilated cardiomyopathy has a multifactorial etiology and pathogenicity, its socioeconomic impact is major, and it represents the leading indication for heart transplantation.1 The pathogenic relationship between viral-induced chronic inflammation and dilated cardiomyopathy may best be illustrated by the meta-analytical observation of the evolution of 21% of acute cases of myocarditis to dilated cardiomyopathy within 33 months of follow-up.2 The prognosis of dilated cardiomyopathy remains grave with conventional pharmacological management, which does not consider the underlying pathogenesis.3 Numerous pathogenically significant autoantibodies directed against cryptic myocardial antigens have been identified in patients with dilated cardiomyopathy. Immunohistochemical quantitative analysis of intramyocardial inflammation and refined molecular biological techniques have begun a new era in the diagnosis of intramyocardial inflammation and viral infection, leading to the description of a new specific disease entity, the inflammatory cardiomyopathy, endorsed by the World Health Organization Task Force on the Definition and Classification of Cardiomyopathies. The etiologic and pathogenic differentiation of dilated cardiomyopathy with reference to inflammation, with or without viral persistence, has fostered promising concepts toward scientifically based treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Noutsias M, Pauschinger M, Kuhl U, et al. Myocarditis and Dilated Cardiomyopathy - New Methods in Diagnosis and Treatment. MMW Fortschr Med 2002;144:36–40.

    PubMed  CAS  Google Scholar 

  2. D’Ambrosio A, Patti G, Manzoli A, et al. The Fate of Acute Myocarditis Between Spontaneous Improvement and Evolution to Dilated Cardiomyopathy. Heart 2001;85:499–504.

    Article  PubMed  Google Scholar 

  3. Mahon NG, Hamid S, McKenna WJ. Prevalence and Natural History of Dilated Cardiomyopathy. Int J Cardiol 2000;75:158–159.

    Article  PubMed  Google Scholar 

  4. Karjalainen J, Heikkila J. Incidence of Three Presentations of Acute Myocarditis in Young Men in Military Service: A 20-Year Experience. Eur Heart J 1999;20:1120–1125.

    Article  PubMed  CAS  Google Scholar 

  5. McCarthy RE HI, Boehmer JP, Hruban RH, et al. Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis. N Engl J Med 2000;342:690–695.

    Article  PubMed  Google Scholar 

  6. Olbrich HG. Epidemiology-Etiology of Dilated Cardiomyopathy. Z Kardiol 2001;90:2–9.

    Article  PubMed  Google Scholar 

  7. Sole MJ, Liu P. Viral Myocarditis: A Paradigm for Understanding the Pathogenesis and Treatment of Dilated Cardiomyopathy. J Am Coll Cardiol 1993;22:99A–105A.

    Article  PubMed  CAS  Google Scholar 

  8. Pauschinger M, Doerner A, Kuehl U, et al. Enteroviral RNA Replication in the Myocardium of Patients with Left Ventricular Dysfunction and Clinically Suspected Myocarditis. Circulation 1999;99:889–895.

    Article  PubMed  CAS  Google Scholar 

  9. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of Adenoviral Genome in the Myocardium of Adult Patients with Idiopathic Left Ventricular Dysfunction. Circulation 1999;99:1348–1354.

    Article  PubMed  CAS  Google Scholar 

  10. Liu PP, Mason JW. Advances in the Understanding of Myocarditis. Circulation 2001; 104:1076–1082.

    Article  PubMed  CAS  Google Scholar 

  11. Matsumori A. Cytokines in Myocarditis and Cardiomyopathies. Curr Opin Cardiol 1996;11:302–309.

    Article  PubMed  CAS  Google Scholar 

  12. Springer TA. Adhesion Receptors of the Immune System. Nature 1990;346:425–434.

    Article  PubMed  CAS  Google Scholar 

  13. Noutsias M, Seeberg B, Schultheiss HP, et al. Expression of Cell Adhesion Molecules in Dilated Cardiomyopathy: Evidence for Endothelial Activation in Inflammatory Cardiomyopathy. Circulation 1999;99:2124–2131.

    Article  PubMed  CAS  Google Scholar 

  14. Dec GW, Jr., Waldman H, Southern J, et al. Viral Myocarditis Mimicking Acute Myocardial Infarction. J Am Coll Cardiol 1992;20:85–89.

    Article  PubMed  Google Scholar 

  15. Lauer B, Niederau C, Kuhl U, et al. Cardiac Troponin T in Patients with Clinically Suspected Myocarditis. J Am Coll Cardiol 1997;30:1354–1359.

    Article  PubMed  CAS  Google Scholar 

  16. Pauschinger M, Knopf D, Petschauer S, et al. Dilated Cardiomyopathy is Associated with Significant Changes in Collagen Type Ml Ratio. Circulation 1999;99:2750–2756.

    Article  PubMed  CAS  Google Scholar 

  17. Caforio AL, Baboonian C, McKenna WJ. Postviral Autoimmune Heart Disease-Fact or Fiction? Eur Heart J 1997;18:1051–1055.

    Article  PubMed  CAS  Google Scholar 

  18. Wessely R, Henke A, Zell R, et al. Low-Level Expression of a Mutant Coxsackieviral cDNA Induces a Myocytopathic Effect in Culture: An Approach to the Study of Enteroviral Persistence in Cardiac Myocytes. Circulation 1998;98:450–457.

    Article  PubMed  CAS  Google Scholar 

  19. Li Y, Bourlet T, Andreoletti L, et al. Enteroviral Capsid Protein VP1 is Present in Myocardial Tissues from Some Patients with Myocarditis or Dilated Cardiomyopathy. Circulation 2000;101:231–234.

    Article  PubMed  CAS  Google Scholar 

  20. Gauntt CJ, Arizpe HM, Higdon AL, et al. Molecular Mimicry, Anti-Coxsackieviius B3 Neutralizing Monoclonal Entibodies, and Myocarditis. J Immunol 1995;154:2983–2995.

    PubMed  CAS  Google Scholar 

  21. Carlquist JF, Menlove RL, Murray MB, et al. HLA Class II (DR and DQ) Antigen Associations in Idiopathic Dilated Cardiomyopathy. Validation Study and Meta-Analysis of Published HLA Association Studies. Circulation 1991;83:515–522.

    Article  PubMed  CAS  Google Scholar 

  22. McKenna CJ, Codd MB, McCann HA, et al. Idiopathic Dilated Cardiomyopathy: Familial Prevalence and HLA Distribution. Heart 1997;77:549–552.

    PubMed  CAS  Google Scholar 

  23. Mahon NG, Madden BP, Caforio AL, et al. Immunohistologic Evidence of Myocardial Disease in Apparently Healthy Relatives of Patients with Dilated Cardiomyopathy. J Am Coll Cardiol 2002;39:455–462.

    Article  PubMed  Google Scholar 

  24. Caforio AL, Keeling PJ, Zachara E, et al. Evidence from Family Studies for Autoimmunity in Dilated Cardiomyopathy. Lancet 1994;344:773–777.

    Article  PubMed  CAS  Google Scholar 

  25. Mahon NG, Zal B, Arno G, et al. Absence of Viral Nucleic Acids in Early and Late Dilated Cardiomyopathy. Heart 2001;86:687–692.

    Article  PubMed  CAS  Google Scholar 

  26. Why HJ, Meany BT, Richardson PJ, et al. Clinical and Prognostic Significance of Detection of Enteroviral RNA in the Myocardium of Patients with Myocarditis or Dilated Cardiomyopathy. Circulation 1994;89:2582–2589.

    Article  PubMed  CAS  Google Scholar 

  27. Terasaki F, Okabe M, Hayashi T, et al. Myocardial Inflammatory Cell Infiltrates in Cases of Dilated Cardiomyopathy: Light Microscopic, Immunohistochemical, and Virological Analyses of Myocardium Specimens Obtained by Partial Left Ventriculectomy. J Card Surg 1999;14:141–146.

    Article  PubMed  CAS  Google Scholar 

  28. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5. Science 1997;275:1320–1323.

    Article  PubMed  CAS  Google Scholar 

  29. Noutsias M, Fechner H, de Jonge H, et al. Human Coxsackie-Adenovirus Receptor is Colocalized with Integrins Alpha(v)Beta(3) and Alpha(v)Beta(5) on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy: Implications for Cardiotropic Viral Infections. Circulation 2001;104:275–280.

    Article  PubMed  CAS  Google Scholar 

  30. Klingel K, Stephan S, Sauter M, et al. Pathogenesis of Murine Enterovirus Myocarditis: Virus Dissemination and Immune Cell Targets. J Virol 1996;70:8888–8895.

    PubMed  CAS  Google Scholar 

  31. Maisch B. “Myokardbiopsien und Perikardioskopien.” In Hess OM, Simon RW, eds. Herzkatheter, Einsatz in Diagnostik und Therapie. Berlin-Heidelberg-New York: Springer, 1999:309–49.

    Google Scholar 

  32. Kuhl U, Pauschinger M, Schultheiss HP. Etiopathogenetic Differentiation of Inflammatory Cardiomyopathy. Immunosuppression and Immunomodulation. Internist 1997;38:590–601.

    Article  PubMed  CAS  Google Scholar 

  33. Strauer BE, Kandolf R, Mall G, et al. Myocarditis—Cardiomyopathy. Consensus Report of the German Association for Internal Medicine, Presented at the 100th Annual Meeting, Wiesbaden, April, 13 1994. Acta Cardiol 1996;51:347–371.

    PubMed  CAS  Google Scholar 

  34. Hauck AJ, Kearney DL, Edwards WD. Evaluation of Postmortem Endomyocardial Biopsy Specimens from 38 Patients with Lymphocytic Myocarditis: Implications for Role of Sampling Error. Mayo Clin Proc 1989;64:1235–1245.

    Article  PubMed  CAS  Google Scholar 

  35. Shanes JG, Ghali J, Billingham ME, et al. Interobserver Variability in the Pathologic Interpretation of Endomyocardial Biopsy Results. Circulation 1987;75:401–405.

    Article  PubMed  CAS  Google Scholar 

  36. Kuhl U, Noutsias M, Seeberg B, et al. Immunohistological Evidence for a Chronic Intramyocardial Inflammatory Process in Dilated Cardiomyopathy. Heart 1996;75:295–300.

    Article  PubMed  CAS  Google Scholar 

  37. Wojnicz R, Nowalany-Kozielska E, Wodniecki J, et al. Immunohistological Diagnosis of Myocarditis. Potential Role of Sarcolemmal Induction of the MHC and ICAM-1 in the Detection of Autoimmune Mediated Myocyte Injury. Eur Heart J 1998;19:1564–1572.

    Article  PubMed  CAS  Google Scholar 

  38. Ino T, Kishiro M, Okubo M, et al. Late Persistent Expressions of ICAM-1 and VCAM-1 on Myocardial Tissue in Children with Lymphocytic Myocarditis. Cardiovasc Res 1997;34:323–328.

    Article  PubMed  CAS  Google Scholar 

  39. Badorff C, Noutsias M, Kuhl U, et al. Cell-Mediated Cytotoxicity in Hearts with Dilated Cardiomyopathy: Correlation with Interstitial Fibrosis and Foci of Activated T Lymphocytes. J Am Coll Cardiol 1997;29:429–434.

    Article  PubMed  CAS  Google Scholar 

  40. Matsumoto G, Nghiem MP, Nozaki N, et al. Cooperation Between CD44 and LFA-1/CDlla Adhesion Receptors in Lymphokine-Activated Killer Cell Cytotoxicity. J Immunol 1998;160:5781–5789.

    PubMed  CAS  Google Scholar 

  41. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results. Circulation 2001;104:3945.

    Article  Google Scholar 

  42. Noutsias M, Pauschinger M, Ostermann K, et al. Digital Image Analysis System for the Quantification of Infiltrates and Cell Adhesion Molecules in Inflammatory Cardiomyopathy. Med Sci Monit 2002;8:59–71.

    Google Scholar 

  43. Jin O, Sole MJ, Butany JW, et al. Detection of Enterovirus RNA in Myocardial Biopsies from Patients with Myocarditis and Cardiomyopathy Using Gene Amplification by Polymerase Chain Reaction. Circulation 1990;82:8–16.

    Article  PubMed  CAS  Google Scholar 

  44. Pauschinger M, Kuhl U, Dorner A, et al. Detection of Enteroviral RNA in Endomyocardial Biopsies in Inflammatory Cardiomyopathy and Idiopathic Dilated Cardiomyopathy. Z Kardiol 1998;87:443–452.

    Article  PubMed  CAS  Google Scholar 

  45. Baboonian C, Treasure T. Meta-Analysis of the Association of Enteroviruses with Human Heart Disease. Heart 1997;78:539–543.

    PubMed  CAS  Google Scholar 

  46. Rohayem J, Dinger J, Fischer R, et al. Fatal Myocarditis Associated with Acute Parvovirus B19 and Human Herpesvirus 6 Coinfection. J Clin Microbiol 2001;39:4585–4587.

    Article  PubMed  CAS  Google Scholar 

  47. Schwimmbeck PL, Schwimmbeck NK, Schultheiss HP, et al. Mapping of Antigenic Determinants of the Adenine-Nucleotide Translocator and Coxsackie B3 Virus with Synthetic Peptides: Use for the Diagnosis of Viral Heart Disease. Clin Immunol Immunopathol 1993;68:135–140.

    Article  PubMed  CAS  Google Scholar 

  48. Schulze K, Becker BF, Schauer R, et al. Antibodies to ADP-ATP Carrier—An Autoantigen in Myocarditis and Dilated Cardiomyopathy—Impair Cardiac Function. Circulation 1990;81:959–969.

    Article  PubMed  CAS  Google Scholar 

  49. Dorner A, Schulze K, Rauch U, et al. Adenine Nucleotide Translocator in Dilated Cardiomyopathy: Pathophysiological Alterations in Expression and Function. Mol Cell Biochem 1997;174:261–269.

    CAS  Google Scholar 

  50. Domer A, Pauschinger M, Schwimmbeck PL, et al. The Shift in the Myocardial Edenine Nucleotide Translocator Isoform Expression Pattern is Associated with an Enteroviral Infection in the Absence of an Active T-Cell Dependent Immune Response in Human Inflammatory Heart Disease. J Am Coll Cardiol 2000;35:1778–1784.

    Article  Google Scholar 

  51. Lauer B, Padberg K, Schultheiss HP, et al. Autoantibodies Against Human Ventricular Myosin in Sera of Patients with Acute and Chronic Myocarditis. J Am Coll Cardiol 1994;23:146–153.

    Article  PubMed  CAS  Google Scholar 

  52. Warraich RS, Dunn MJ, Yacoub MH. Subclass Specificity of Autoantibodies Against Myosin in Patients with Idiopathic Dilated Cardiomyopathy: Pro-Inflammatory Antibodies in DCM Patients. Biochem Biophys Res Commun 1999;259:255–261.

    Article  PubMed  CAS  Google Scholar 

  53. Warraich RS, Noutsias M, Kasac I, et al. Immunoglobin G3 Cardiac Myosin Autoantibodies Correlate with Left Ventricular Dysfunction in Patients with Dilated Cardiomyopathy. Am Heart J 2002;143:1076–1084.

    Article  PubMed  CAS  Google Scholar 

  54. Limas C, Limas CJ, Boudoulas H, et al. Anti-Beta-Receptor Antibodies in Familial Cardiomyopathy: Correlation with HLA-DR and HLA-DQ Gene Polymorphisms. Am Heart J 1994;127:382–386.

    Article  PubMed  CAS  Google Scholar 

  55. Dorffel WV, Wallukat G, Baumann G, et al. Immunoadsorption in Dilated Cardiomyopathy. Ther Apher 2000;4:235–238.

    Article  PubMed  CAS  Google Scholar 

  56. Mason JW, O’Connell JB, Herskowitz A, et al. A Clinical Trial of Immunosuppressive Therapy for Myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269–275.

    Article  PubMed  CAS  Google Scholar 

  57. Maisch B, Camerini F, Schultheiss HP. Immunosuppressive Therapy for Myocarditis. N Engl J Med 1995;333:1713–1714.

    Article  PubMed  CAS  Google Scholar 

  58. Kuhl U, Schultheiss HP. Treatment of Chronic Myocarditis with Corticosteroids. Eur Heart J 1995;16:168–172.

    Article  PubMed  Google Scholar 

  59. Parrillo JE. Inflammatory Cardiomyopathy (Myocarditis): Which Patients Should be Treated with Anti-Inflammatory Therapy? Circulation 2001; 104:4–6.

    Article  PubMed  CAS  Google Scholar 

  60. Felix SB, Staudt A, Dorffel WV, et al. Hemodynamic Effects of Immunoadsorption and Subsequent Immunoglobulin Substitution in Dilated Cardiomyopathy: Three-Month Results from a Randomized Study. J Am Coll Cardiol 2000;35:1590–1598.

    Article  PubMed  CAS  Google Scholar 

  61. Felix SB, Staudt A, Landsberger M, et al. Removal of Cardiodepressant Antibodies in Dilated Cardiomyopathy by Immunoadsorption. J Am Coll Cardiol 2002;39:646–652.

    Article  PubMed  CAS  Google Scholar 

  62. Staudt A, Schaper F, Stangl V, et al. Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution. Circulation 2001;103:2681–2686.

    Article  PubMed  CAS  Google Scholar 

  63. Chimenti C, Calabrese F, Pieroni M, et al. Active Lymphocytic Myocarditis: Virologic and Immunologic Profile of Responders Versus Non-Responders to Immunosuppressive Therapy. Circulation 2001;104:II-559.

    Article  Google Scholar 

  64. Heim A, Grumbach I, Pring-Akerblom P, et al. Inhibition of Coxsackievirus B3 Carrier State Infection of Cultured Human Myocardial Fibroblasts by Ribavirin and Human Natural Interferon-Alpha. Antiviral Res 1997;34:101–111.

    Article  PubMed  CAS  Google Scholar 

  65. Horwitz MS, La Cava A, Fine C, et al. Pancreatic Expression of Interferon-Gamma Protects Mice from Lethal Coxsackievirus B3 Infection and Subsequent Myocarditis. Nat Med 2000;6:693–697.

    Article  PubMed  CAS  Google Scholar 

  66. Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-beta Treatment of Patients with Enteroviral and Adenoviral Cardiomyopathy Causes Effective Virus Clearance and Long-Term Clinical Improvement. Circulation 2001;104:II-682.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Noutsias, M., Pauschinger, M., Kuhl, U., Schultheiss, HP. (2003). Autoimmunity in Cardiomyopathies. In: Matsumori, A. (eds) Cardiomyopathies and Heart Failure. Developments in Cardiovascular Medicine, vol 248. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9264-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9264-2_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4865-8

  • Online ISBN: 978-1-4419-9264-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics